Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Challenge Finder aim to become the number 1 place for athletes to find, store and book events. They have built up a platform of over 3000 users and will use the funding for marketing and further development, and are generating revenue through event marketing, advertising and commissions on the bookings.
days to go:
Expired
investment:
£121,510
Hansine is a luxury resort wear brand designed with strong ethical values and produced in London to the booming global market sector. The product's initial launch has proved its global demand with retailers like Liberty and Neiman Marcus. Hansine aims at becoming a definitive luxury destination wear brand. This brand has been worn by the topmost global influencers, and it has been featured by high-profile media platforms such as FT, Elle, Grazia, and The Telegraph. With the proceeds, the company will invest in production, facilitate the third phase of the business plan, staffing and marketing.
days to go:
Expired
investment:
£56,820
The Idle Man is a fast growing internet retailer with experienced founders. Within the third month of trading The Idle Man was already seeing £100,000 in monthly revenue. This funding round they are aiming to use the money gained from investments to continue their aggressive expansion.
days to go:
Expired
investment:
£1,283,974
OpenPlay is a marketplace for sports facilities and activities. It makes it easier for the public to find and book local venues and activities. It has a social layer on top to connect people to each other around their sporting interests and abilities. It makes money via a mixture of a subscription (SAAS) and commission based model for the use of its online bookings and customer management tools. We already have 80,000+ monthly visitors, 100,000+ bookings and over 2,000 venues listed.
days to go:
Expired
investment:
£75,000
Net An Agent is a price comparison site for estate agents. After filling out a few details, you can instantly receive quotes from high-street and online estate agents. When you're ready, you can request a valuation and then pick which agent you'd like to market your property.
days to go:
Expired
investment:
£6,584
PathCloud aims to assemble the global clinical diagnostics resources and data and make them safely available and helpful. The company has created and tested one of the first scalable clinical diagnostics management platforms. It currently has 20,000 clinicians partner networks and 92 registered clinicians. Additionally, it has a network across 48 counties, has over 100 providers, over 3500 diagnostics tests registered and over 10,000 patients by partner telemedicine networks. These funds will be used to gain a significant portion of diagnostics supplier agreements towards the scaling objective, increase efforts towards the international markets and NHS and pursue telemedicine networks.
days to go:
Expired
investment:
£81,720
